City of Brampton celebrates Sun Pharma expansion and investment in Brampton’s health and life sciences sector
New pharmaceutical manufacturing investment strengthens Brampton’s position as a destination for global business growth and innovation
The Voice of Canada News
The City of Brampton celebrated the expansion of Sun Pharma’s Brampton operations with a ribbon-cutting ceremony recognizing more than $56 million in investment and over 35 new jobs supporting the city’s growing health and life sciences sector. With over 740 skilled workers currently employed at Sun Pharma’s Brampton facility, the expansion further strengthens Brampton’s position as a hub for health and life sciences innovation and employment.
Mayor Patrick Brown and Members of Council joined senior Sun Pharma leadership, including Prakash Naik, Sr. VP Manufacturing (North America), Chetan Dhotre, Associate VP (Brampton) and Masoud Ronaghi, Associate Director, Facilities & Engineering (Brampton) for the ribbon-cutting ceremony and facility tour recognizing the company’s latest investment and expansion in Brampton.
.jpg?RenditionID=16)
Mayor Patrick Brown and Members of Council joined Sun Pharma leadership for the ribbon-cutting ceremony and facility tour recognizing the company’s latest investment and expansion in Brampton. Credit: City of Brampton.
The investment includes the transformation of the facility into a highly specialized pharmaceutical operation, including a new 50,000-square-foot environmentally controlled warehouse with capacity for approximately 4,500 pallets, a highly regulated pharmaceutical production suite and the installation of a state-of-the-art Quick Changeover Tube Filling line. Additional investments are also planned for the company’s existing facilities at 126 and 130 East Drive.
Sun Pharma’s continued growth in Brampton reflects the city’s strength as a destination for foreign direct investment and advanced manufacturing. As a global pharmaceutical company headquartered in India, Sun Pharma’s decision to continue expanding in Brampton demonstrates confidence in the city’s strategic direction, skilled workforce, and growing innovation ecosystem.
The investment reinforces Brampton’s position as a destination for industrial investment and underscores the importance of reinvesting in established employment areas that continue to support business growth and job creation.
Strengthening Brampton’s health and life sciences sector
Sun Pharma has been an active partner in advancing Brampton’s health and life sciences sector, including participation in the City’s MedTech Task Force alongside healthcare, academic and industry leaders helping shape the future of medical innovation in Brampton.
Brampton’s health and life sciences ecosystem continues to grow through partnerships, infrastructure investments and innovation-focused initiatives, including the opening of the Toronto Metropolitan University School of Medicine, the advancement of Peel Memorial’s new patient tower and emergency department and continued investment from leading health and pharmaceutical companies.
As one of Brampton’s major employers within the pharmaceutical manufacturing sector, Sun Pharma’s continued investment further strengthens the city’s position within Ontario’s life sciences and advanced manufacturing economy while supporting local employment and economic growth.
About Sun Pharma
Sun Pharmaceutical Industries Ltd. is one of the world’s largest specialty generic pharmaceutical companies, providing high-quality medicines and healthcare products globally. Operating in Canada through Sun Pharma Canada Inc., the company manufactures and distributes a broad portfolio of innovative medicines, generic pharmaceuticals and consumer healthcare products.
The Brampton operations play an important role in the company’s North American manufacturing network, producing pharmaceutical products for Canadian and international markets through advanced production, packaging and quality-controlled manufacturing operations.
Quotes
“Foreign direct investment plays an important role in driving economic growth and creating opportunities for residents and businesses across Brampton. Sun Pharma’s expansion demonstrates how global companies are choosing Brampton because of our talented workforce, strategic location and strong business environment. Investments like this help strengthen our local economy and support long-term growth in key sectors.” – Patrick Brown, Mayor, City of Brampton
“As a member of the City’s MedTech Task Force, Sun Pharma has played an important role in advancing Brampton’s health and life sciences ecosystem, helping strengthen the partnerships that drive innovation and support future growth. Their continued investment in Brampton is a strong vote of confidence in our city and its economic potential. As a global company choosing to grow here, Sun Pharma is creating skilled local jobs, strengthening our economy and further reinforcing Brampton’s reputation as a leader in health and life sciences, innovation and advanced manufacturing.”– Harkirat Singh, Deputy Mayor; Regional Councillor, Wards 9 & 10; Chair, MedTech Task Force, City of Brampton
“Sun Pharma’s continued investment in Brampton is a strong reflection of the confidence global companies have in our city and its future. This expansion strengthens Brampton’s growing health and life sciences sector, creates local jobs and reinforces our position as a destination for innovation, advanced manufacturing and international investment.” – Gurpartap Singh Toor, Regional Councillor, Wards 9 & 10; Chair, Economic Development, City of Brampton
“Brampton’s strength has always been its people. Sun Pharma’s expansion highlights the depth of talent, expertise and diversity that make our city an attractive place for companies to grow. As our health and life sciences sector continues to evolve, investments like this help create opportunities for residents, support career growth and contribute to a more innovative and inclusive economy.” – Rowena Santos, Regional Councillor, Wards 1 & 5; Vice-Chair, Economic Development, City of Brampton
“Sun Pharma’s continued investment in Brampton is helping create jobs and support economic growth right here in our community. Expansions like this strengthen our local workforce, support families and reinforce Brampton’s position as a city where businesses continue to grow and invest for the future.” – Pat Fortini, Regional Councillor, Wards 7 & 8, City of Brampton
“Investments like this create meaningful opportunities for residents and continue to strengthen Brampton’s local economy. Sun Pharma’s expansion represents continued confidence in our community, supporting high-quality jobs and long-term growth within one of Brampton’s key industries.” – Rod Power, City Councillor, Wards 7 & 8, City of Brampton
“In partnership with the City of Brampton, we are excited to expand a facility that already produces a significant amount of the medicines Sun Pharma supplies to Canada. This growth enhances our ability to support patients and customers across Canada, and we look forward to building our presence even further in a city renowned as a destination for the health sector and advanced manufacturing.” – Rick Ascroft, CEO, North America, Sun Pharma
